Our data indicate that inhibiting PCSK9 significantly attenuated migrative ability and transition of MLE-12 cells, regulating EMT biomarker expression in both BLM-induced mouse and TGF-β-induced cell experiments. Here, PCSK9 is linked to Bloom syndrome.